Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL231296 | 1.00 | SOAT2 (0.49) | SOAT2SOAT1 | |
| SCHEMBL19809120 | 0.88 | SOAT2 (0.49) | SOAT2SOAT1 | |
| SCHEMBL231297 | 0.88 | SOAT2 (0.52) | SOAT2SOAT1 | |
| SCHEMBL17200181 | 0.88 | SOAT2 (0.54) | SOAT2SOAT1 | |
| SCHEMBL17200182 | 0.88 | SOAT2 (0.49) | SOAT2SOAT1 | |
| SCHEMBL233526 | 0.87 | SOAT2 (0.60) | SOAT2SOAT1 | |
| SCHEMBL15455939 | 0.87 | SOAT2 (0.60) | SOAT2SOAT1 | |
| SCHEMBL895914 | 0.87 | SOAT2 (0.60) | SOAT2SOAT1 | |
| SCHEMBL1279906 | 0.85 | SOAT2 (0.62) | SOAT2SOAT1 | |
| SCHEMBL18803185 | 0.82 | SOAT2 (0.38) | SOAT2SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150305334-A1 | USE OF SUBSTITUTED 1-(ARYL ETHYNYL)-, 1-(HETEROARYL ETHYNYL)-, 1-(HETEROCYCLYL ETHYNYL)- AND 1-(CYCLOALKENYL ETHYNYL)-CYCLOHEXANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS | BAYER CROPSCIENCE AG (DE) | 2015-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150305334-A1 | USE OF SUBSTITUTED 1-(ARYL ETHYNYL)-, 1-(HETEROARYL ETHYNYL)-, 1-(HETEROCYCLYL ETHYNYL)- AND 1-(CYCLOALKENYL ETHYNYL)-CYCLOHEXANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS | CBR1, CAT, NAT1 | SOAT2 2034/4885SOAT1 1639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.